A prospective, randomized, sequential crossover trial of large-volume versus normal-volume leukapheresis procedures: Effects on serum electrolytes, platelet counts, and other coagulation measures

Transfusion

Volumn 40, Issue 3, 2000, Pages 368-374

  Humpe, Andreas ^a,b   Riggert, J ^a   Munzel, U ^a   Kohler M ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLOOD CLOTTING FACTOR 10A; CARMUSTINE; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; HEPARIN; IFOSFAMIDE; MELPHALAN; METHOTREXATE; MITOXANTRONE; PREDNIMUSTINE; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD CLOTTING; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ELECTROLYTE BLOOD LEVEL; FEMALE; HUMAN; LEUKAPHERESIS; MALE; NONHODGKIN LYMPHOMA; PARTIAL THROMBOPLASTIN TIME; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT;

ADULT; ANTICOAGULANTS; BLOOD COAGULATION FACTORS; BREAST NEOPLASMS; CROSS-OVER STUDIES; ELECTROLYTES; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKAPHERESIS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PLATELET COUNT; PROSPECTIVE STUDIES;

EID: 0034121331     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40030368.x     Document Type: Article

References (32)

1. To LB, Juttner CA, Stomski F, et al. Immune reconstitution following peripheral blood stem cell autografting (letter). Bone Marrow Transplant 1987;2:111-2.
2. Korbling M, Dorken B, Ho AD, et al. Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood 1986;67:529-32.
3. Gillespie TW, Hillyer CD. Peripheral blood progenitor cells for marrow reconstitution: mobilization and collection strategies. Transfusion 1996;36:611-24.
4. Kessinger A, Armitage JO, Landmark JD, et al. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988;71:723-7.
5. Hillyer CD, Swenson RB, Hart KK, et al. Peripheral blood stem cell acquisition by large-volume leukapheresis in growth factor-stimulated and unstimulated rhesus monkeys: development of an animal model. Exp Hematol 1993;21:1455-9.
6. Hillyer CD, Lackey DA III, Hart KK, et al. CD34+ progenitors and colony-forming units-granulocyte macrophage are recruited during large-volume leukapheresis and concentrated by counterflow centrifugal elutriation. Transfusion 1993;33:316-21.
7. Hillyer CD. Large volume leukapheresis to maximize peripheral blood stem cell collection. J Hematother 1993;2:529-32.
8. Humpe A, Riggert J, Munzel U, et al. A prospective, randomized, sequential crossover trial of large-volume leukapheresis and normal-volume leukaphereses: effect on progenitor cells and engraftment. Transfusion 1999;39:1120-7.
9. Pettengell R, Morgenstern GR, Woll PJ, et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 1993;82:3770-7.
10. Negrin RS, Kusnierz-Glaz CR, Still BJ, et al. Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. Blood 1995;85:3334-41.
11. Ketterer N, Salles G, Raba M, et al. High CD34(+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation. Blood 1998;91:3148-55.
12. Comenzo RL, Vosburgh E, Weintraub LR, et al. Collection of mobilized blood progenitor cells for hematopoietic rescue by large-volume leukapheresis. Transfusion 1995;35:493-7.
13. Comenzo RL, Malachowski ME, Miller KB, et al. Large-volume leukapheresis for collection of mononuclear cells for hematopoietic rescue in Hodgkin's disease. Transfusion 1995;35:42-5.
14. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood 1997;89:2233-58.
15. Malachowski ME, Comenzo RL, Hillyer CD, et al. Large-volume leukapheresis for peripheral blood stem cell collection in patients with hematologic malignancies. Transfusion 1992;32:732-5.
16. Riggert J, Schwartz DWM, Wieding JU, et al. Prestorage inline filtration of whole blood for obtaining white cell-reduced blood components. Transfusion 1997;37:1039-44.
17. Greinacher A, Michels I, Kiefel V, Mueller-Eckhardt C. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost 1991;66:734-6.
18. Munzel U. Nonparametric methods for paired samples. Stat Neerlandica 1999;53:277-86.
19. Reik RA, Noto TA, Fernandez HF. Safety of large-volume leukapheresis for collection of peripheral blood progenitor cells. J Clin Apheresis 1997;12:10-3.
20. Vengelen-Tyler V, ed. Technical manual. 12th ed. Bethesda: American Association of Blood Banks, 1996.
21. Voak D, Cann R, Finney RD, et al. Guidelines for the collection, processing and storage of human bone marrow and peripheral stem cells for transplantation. Prepared by the BCSH Blood Transfusion Task Force. Transfus Med 1994;4:165-72.
22. Bushinsky DA, Monk RD. Calcium. Lancet 1998;352:306-11.
23. Halperin ML, Kamel KS. Potassium. Lancet 1998;352:135-40.
24. Estivals M, Pelzer H, Sie P, et al. Prothrombin fragment 1 + 2, thrombin-antithrombin III complexes and D- dimers in acute deep vein thrombosis: effects of heparin treatment. Br J Haematol 1991;78:421-4.
25. Urlesberger B, Zobel G, Rodl S, et al. Activation of the clotting system: heparin-coated versus non coated systems for extracorporeal circulation. Int J Artif Organs 1997;20:708-12.
26. Toulon P, Boutiere B, Horellou MH, et al. Monitoring heparin therapy using activated partial thromboplastin time - results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparin. Thromb Haemost 1998;80:104-8.
27. Van der Velde EA, Poller L. The APTT monitoring of heparin - the ISTH/ICSH collaborative study. Thromb Haemost 1995;73:73-81.
28. Hirsh J, Raschke R, Warkentin TE, et al. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 1995;108(4 Suppl):258S-75S.
29. Campbell NR, Hull RD, Brant R, et al. Different effects of heparin in males and females. Clin Invest Med 1998;21:71-8.
30. Monreal M, Urrutia A, Marti S, et al. Platelet count and the risk of bleeding in hospitalized patients with venous thromboembolism starting anticoagulant therapy. Haemostasis 1997;27:91-8.
31. Levine MN, Raskob G, Landefeld S, Hirsh J. Hemorrhagic complications of anticoagulant treatment. Chest 1995;108(4 Suppl):276S-90S.
32. Wester JP, de Valk HW, Nieuwenhuis HK, et al. Risk factors for bleeding during treatment of acute venous thromboembolism. Thromb Haemost 1996;76:682-8.